Doolittle & Ganos Investment Counsel »

GlaxoSmithKline shares owned by Doolittle & Ganos Investment Counsel

Quarter-by-quarter ownership of GlaxoSmithKline shares owned by Doolittle & Ganos Investment Counsel from 13F filings

Historical chart of Doolittle & Ganos Investment Counsel investment in GlaxoSmithKline

Tip: Access up to 7 years of quarterly data

All positions including GlaxoSmithKline held by Doolittle & Ganos Investment Counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GlaxoSmithKline by Doolittle & Ganos Investment Counsel

Quarter filed Position value Share count Share price at filing
2011-03-31 $156k 3.9k 40.00
2010-12-31 $149k 3.8k 39.21

More positions owned by Doolittle & Ganos Investment Counsel

Templeton Emerging Markets Income Fund (TEI)
Templeton Global Income Fund (SABA)
SPDR DJ International Real Estate ETF (RWX)
Ubs Ag Jersey Brh Alerian Infrst
iShares FTSE EPRA/NAREIT Dev Gl Real ETF (IFGL)
SPDR Gold Trust (GLD)
Ares Capital Corporation (ARCC)
Chevron Corporation (CVX)
Apollo Investment
Apple (AAPL)
General Electric Company
Union Pacific Corporation (UNP)
Exxon Mobil Corporation (XOM)
Mortgage Reit Index real (REM)
iShares MSCI Emerging Markets Indx (EEM)

View all positions for Doolittle & Ganos Investment Counsel

Top funds holding GlaxoSmithKline

Columbia Asset Management
Paradigm Asset Management Company
Accent Capital Management
Park Circle
Byrne Asset Management
Retirement Group
Huntington National Bank

View all funds holding GlaxoSmithKline